BERKELEY, Calif.--(BUSINESS WIRE)--Caribou Biosciences, a developer of technology-based solutions for cellular engineering, today announced the presentation of new findings demonstrating the advancement of its proprietary CRISPR-Cas9 gene editing and repair technology platform. These findings were presented this week in two poster sessions at The Keystone Symposium for Precision Genome Engineering and Synthetic Biology in Big Sky, Montana.
In the first presentation, entitled "Modulation of Cas9 Activity Through Single Guide RNA Engineering," researchers demonstrated that single guide RNA (sgRNA) can be engineered to modify the activity and improve the specificity of Cas9 for genome editing. The presentation expands upon findings previously published by Caribou and collaborators in the journal Molecular Cell in October 2014. The presentation findings were also the basis of a talk given at the Advances in Genome Editing workshop at the Symposium.
Help employers find you! Check out all the jobs and post your resume.
In the first presentation, entitled "Modulation of Cas9 Activity Through Single Guide RNA Engineering," researchers demonstrated that single guide RNA (sgRNA) can be engineered to modify the activity and improve the specificity of Cas9 for genome editing. The presentation expands upon findings previously published by Caribou and collaborators in the journal Molecular Cell in October 2014. The presentation findings were also the basis of a talk given at the Advances in Genome Editing workshop at the Symposium.
Help employers find you! Check out all the jobs and post your resume.
